RPRX Royalty Pharma plc
Price Chart
Executive Summary
Two insiders at Royalty Pharma sold a combined $883K in open-market transactions over a one-week window. The sales represent ~0.003% of the $30.6B market cap, a trivial amount that is routine and non-informative. No material business catalyst is evident from the filing.
Key Financial Metrics
Actionable Insight
The dollar amount is too small to signal any material change in business outlook. Monitor upcoming quarterly earnings for any fundamental shifts; these sales are routine and non-actionable.
Key Facts
- Director Norden Gregory sold 3,000 shares at ~$53.00 for $161K on 2026-05-14.
- EVP Marshall Urist sold 13,684 shares at ~$52.75 for $722K on 2026-05-20.
- Total insider sales of $883K represent ~0.003% of RPRX's $30.6B market cap.
- No insider purchases were reported in the cluster window.
- Recent 30-day insider activity includes 4 prior sales totaling $3.2M, consistent with routine liquidity-driven selling.
Financial Impact
Total insider sales of $883K, or ~0.003% of market cap — economically negligible.
Risk Factors
- Insider sales could increase if the stock continues to appreciate, but no bearish signal is present here.
- No identifiable catalyst from this filing alone.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RPRX-1779412846308 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
12d ago
|
Insider Cluster
| $55.76 $55.87 | ▲ +0.20% | ▲ +2.72% | $54.86 (−1.61%) |
|
May 28, 2026
12d ago
|
8-K
| $55.76 $54.97 | ▼ −1.42% | ▼ −1.12% | $54.86 (−1.61%) |
|
May 22, 2026
19d ago
|
Insider Cluster
| $54.50 $55.18 | ▲ +1.25% | ▼ −0.41% | $54.86 (+0.66%) |
|
May 15, 2026
25d ago
|
Insider Cluster
| $52.07 $53.86 | ▲ +3.44% | ▲ +1.82% | $54.86 (+5.36%) |
|
May 14, 2026
26d ago
|
144
| $52.85 $54.50 | ▲ +3.12% | ▲ +2.16% | $54.86 (+3.80%) |
|
May 6, 2026
4w ago
|
8-K
| $50.72 $51.70 | ▲ +1.93% | ▲ +0.80% | $54.86 (+8.16%) |
|
Apr 17, 2026
7w ago
|
Press Release
| $50.00 $49.38 | ▼ −1.24% | ▼ −1.79% | $54.86 (+9.72%) |
|
Apr 15, 2026
7w ago
|
Press Release
| $48.48 $49.64 | ▲ +2.39% | ▲ +1.41% | $54.86 (+13.16%) |
|
Apr 10, 2026
8w ago
|
DEFA14A
| $48.43 $49.30 | ▲ +1.80% | ▼ −1.50% | $54.86 (+13.28%) |
|
Mar 30, 2026
10w ago
|
Press Release
| $46.37 $46.87 | ▲ +1.08% | ▼ −3.22% | $54.86 (+18.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access